Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | 166,844 | reported | 05 May 2026 | tx 93+874,470−320,546 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 May 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 4,000 | 4.30 USD | 10b5-1 |
| 05 May 2026 | SALE | Cullinan Therapeutics, Inc. | 7,800 | 14.60 USD | 10b5-1 |
| 05 May 2026 | SALE | Cullinan Therapeutics, Inc. | 200 | 15.58 USD | 10b5-1 |
| 05 May 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 4,000 | 0.00 USD | 10b5-1deriv |
| 05 Mar 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 4,000 | 4.30 USD | |
| 05 Mar 2026 | SALE | Cullinan Therapeutics, Inc. | 8,000 | 15.68 USD | |
| 05 Mar 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 25 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 1,780 | 14.14 USD | |
| 24 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 3,601 | 14.47 USD | |
| 23 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 1,752 | 13.99 USD | |
| 20 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 8,000 | 14.30 USD | |
| 20 Feb 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 8,000 | 4.30 USD | |
| 20 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 3,742 | 13.62 USD | |
| 20 Feb 2026 | EXERCISE | Cullinan Therapeutics, Inc. | 8,000 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 57,500 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 115,000 | 0.00 USD | deriv |
| 12 Feb 2026 | SALE | Cullinan Therapeutics, Inc. | 416 | 12.03 USD | |
| 22 Jan 2026 | SALE | Cullinan Therapeutics, Inc. | 4,000 | 12.30 USD | |
| 19 Dec 2025 | SALE | Cullinan Therapeutics, Inc. | 1,345 | 10.01 USD | |
| 18 Dec 2025 | SALE | Cullinan Therapeutics, Inc. | 2,898 | 9.67 USD | |
| 15 Dec 2025 | SALE | Cullinan Therapeutics, Inc. | 995 | 11.90 USD | |
| 12 Dec 2025 | SALE | Cullinan Therapeutics, Inc. | 2,148 | 12.38 USD | |
| 24 Nov 2025 | SALE | Cullinan Therapeutics, Inc. | 4,000 | 12.30 USD | |
| 25 Feb 2025 | SALE | Cullinan Therapeutics, Inc. | 3,756 | 8.53 USD | |
| 19 Feb 2025 | GRANT_AWARD | Cullinan Therapeutics, Inc. | 50,000 | 0.00 USD |